文献速递其他结缔组织病

携带DNASE1L3 R206C变异的系统性硬化症患者循环基因组DNA消化减少

Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该研究探讨DNASE1L3 R206C变异对系统性硬化症(SSc)患者循环基因组DNA消化的影响。体外实验证实DNASE1L3可消化凋亡来源膜囊泡(AdMV)相关基因组DNA,R206C变异损害其细胞外分泌;携带R206C变异的SSc患者血浆对AdMV相关基因组DNA消化能力降低,且长/短基因组DNA片段比值升高并与DNase活性负相关。结论认为循环基因组DNA是DNASE1L3的生理性底物,携带R206C变异的SSc患者其消化减少。

要点

  • DNASE1L3 R206C变异导致其细胞外分泌受损,血浆消化AdMV相关基因组DNA能力降低。
  • 携带R206C变异的SSc患者血浆长/短基因组DNA片段比值升高,且与DNase活性呈负相关。
  • 循环基因组DNA是DNASE1L3的生理性底物,R206C变异患者其消化减少。

核心结论

  • 研究结果证实循环基因组DNA是DNASE1L3的生理性底物,并显示携带DNASE1L3 R206C变异的SSc患者其消化减少。

研究设计与样本

  • 研究在体外测试DNASE1L3消化AdMV相关基因组DNA的能力,并使用转染细胞系及来自SSc患者的原代单核细胞衍生树突状细胞检测R206C变异对细胞外分泌的影响。
  • 比较携带DNASE1L3 R206C或R206野生型的SSc患者与健康对照(HCs)血浆消化AdMV相关基因组DNA的能力。
  • 通过测量长/短基因组DNA片段比例,测定123例SSc患者和74例HCs血浆中内源性基因组DNA的消化状态。

主要发现

  • 体外实验确认DNASE1L3具有消化AdMV相关基因组DNA的独特能力。
  • DNASE1L3 R206C的细胞外分泌受损。
  • 携带DNASE1L3 R206C个体的血浆消化AdMV相关基因组DNA的能力降低。
  • 携带DNASE1L3 R206C的SSc患者血浆中长/短基因组DNA片段比值升高,且该比值与DNase活性呈负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Polymorphism in a coding region of deoxyribonuclease I-like III (DNASE1L3), causing amino acid substitution of Arg-206 to Cys (R206C), is a robustly replicated heritable risk factor for SSc and other autoimmune diseases. DNASE1L3 is secreted into the circulation, where it can digest genomic DNA (gDNA) in apoptosis-derived membrane vesicles (AdMVs). We sought to determine the impact of DNASE1L3 R206C on digestion of circulating gDNA in SSc patients and healthy controls (HCs). METHODS: The ability of DNASE1L3 to digest AdMV-associated gDNA was tested in vitro. The effect of R206C substitution on extracellular secretion of DNASE1L3 was determined using a transfected cell line and primary monocyte-derived dendritic cells from SSc patients. Plasma samples from SSc patients and HCs with DNASE1L3 R206C or R206 wild type were compared for their ability to digest AdMV-associated gDNA. The digestion status of endogenous gDNA in plasma samples from 123 SSc patients and 74 HCs was determined by measuring the proportion of relatively long to short gDNA fragments. RESULTS: The unique ability of DNASE1L3 to digest AdMV-associated gDNA was confirmed. Extracellular secretion of DNASE1L3 R206C was impaired. Plasma from individuals with DNASE1L3 R206C had reduced ability to digest AdMV-associated gDNA. The ratio of long: short gDNA fragments was increased in plasma from SSc patients with DNASE1L3 R206C, and this ratio correlated inversely with DNase activity. CONCLUSION: Our results confirm that circulating gDNA is a physiological DNASE1L3 substrate and show that its digestion is reduced in SSc patients with the DNASE1L3 R206C variant.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Skaug B, Guo X, Li YJ, et al. Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant. Rheumatology (Oxford). 2023. PMID: 36708011. doi:10.1093/rheumatology/kead050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。